The New England journal of medicine, 2018-09, Vol.379 (11), p.1007-1016
- Maurer, Mathew S
- Schwartz, Jeffrey H
- Gundapaneni, Balarama
- Elliott, Perry M
- Merlini, Giampaolo
- Waddington-Cruz, Marcia
- Kristen, Arnt V
- Grogan, Martha
- Witteles, Ronald
- Damy, Thibaud
- Drachman, Brian M
- Shah, Sanjiv J
- Hanna, Mazen
- Judge, Daniel P
- Barsdorf, Alexandra I
- Huber, Peter
- Patterson, Terrell A
- Riley, Steven
- Schumacher, Jennifer
- Stewart, Michelle
- Sultan, Marla B
- Rapezzi, Claudio
2018
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Maurer, Mathew S
- Schwartz, Jeffrey H
- Gundapaneni, Balarama
- Elliott, Perry M
- Merlini, Giampaolo
- Waddington-Cruz, Marcia
- Kristen, Arnt V
- Grogan, Martha
- Witteles, Ronald
- Damy, Thibaud
- Drachman, Brian M
- Shah, Sanjiv J
- Hanna, Mazen
- Judge, Daniel P
- Barsdorf, Alexandra I
- Huber, Peter
- Patterson, Terrell A
- Riley, Steven
- Schumacher, Jennifer
- Stewart, Michelle
- Sultan, Marla B
- Rapezzi, Claudio
- Titel
- Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
- Ist Teil von
- The New England journal of medicine, 2018-09, Vol.379 (11), p.1007-1016
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2018
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- In this randomized, controlled, phase 3 trial of tafamidis for transthyretin amyloid cardiomyopathy, tafamidis was associated with lower all-cause mortality and lower rates of cardiovascular-related hospitalizations and decline in functional capacity and quality of life.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa1805689Titel-ID: cdi_proquest_journals_2103046415
- Format
- –
- Schlagworte
- Administration, Oral, Aged, Aged, 80 and over, Amyloid Neuropathies, Familial - complications, Amyloid Neuropathies, Familial - drug therapy, Amyloidogenesis, Benzoxazoles - adverse effects, Benzoxazoles - therapeutic use, Binding sites, Biopsy, Cardiomyopathies - complications, Cardiomyopathies - drug therapy, Cardiomyopathy, Cardiovascular diseases, Disease Progression, Double-Blind Method, Female, Fibrils, Heart failure, Heart Failure - etiology, Heart Failure - mortality, Hospitalization - statistics & numerical data, Humans, Male, Medical prognosis, Middle Aged, Mortality, Mutation, Myocardium, Patient safety, Patients, Prealbumin - antagonists & inhibitors, Proteins, Quality of Life, Survival Analysis, Transthyretin, Walk Test